Back to Newsroom

Corbus Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference

NORWOOD, MA — (Marketwired) — 09/14/17 — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that Yuval Cohen, Ph.D., Chief Executive Officer, will present at the Cantor Fitzgerald Global Healthcare Conference on Monday, September 25, 2017 at 8:35 a.m. EDT in New York, NY.
READ MORE…